A randomized controlled study of the treatment of radiation induced skin injury by Erhuang Decoctio

Phase 3

Recruiting

• Conditions: Radiation induced skin injury

• Registration Number: ITMCTR2000004137
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Diagnosed as a malignant tumor by pathology or cytology;
2. Patients with grade 2 or 3 radiation-induced skin injury after radiotherapy (Using RTOG acute radiation injury classification standard, Tumor radiotherapy, 3rd Edition, edited by Yin Weibai and Gu Xianzhi);
3. Aged between 18 and 70 years;
4. No history of systematic use of corticosteroids and antihistamines in the last 2 weeks and no history of external use of such drugs within 1 week.

Exclusion Criteria

1. Patients with systemic or contact drug allergy history;
2. Patients with local skin lesions complicated with bacterial or fungal infection;
3. Patients with severe endocrine, cardiovascular, blood, liver and kidney diseases and low immune function.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin lesion remission rate;

Secondary Outcome Measures

Name	Time	Method
Changes in the degree of pain;Symptoms, signs and TCM Syndromes of skin lesions;Quality of life;